BE899987A - Nouvelles compositions pharmaceutiques antitumorales. - Google Patents

Nouvelles compositions pharmaceutiques antitumorales.

Info

Publication number
BE899987A
BE899987A BE0/213197A BE213197A BE899987A BE 899987 A BE899987 A BE 899987A BE 0/213197 A BE0/213197 A BE 0/213197A BE 213197 A BE213197 A BE 213197A BE 899987 A BE899987 A BE 899987A
Authority
BE
Belgium
Prior art keywords
tumors
pharmaceutical compositions
new antitumor
antitumor pharmaceutical
valepotriates
Prior art date
Application number
BE0/213197A
Other languages
English (en)
Inventor
P W Thies
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of BE899987A publication Critical patent/BE899987A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Utilisation de valépotriates en doses quotidiennes propres à inhiber efficacement les tumeurs qui sont d'au moins 700 mg par jour en vue du traitement curatif ou prophylactique de tumeurs et en particulier de tumeurs malignes telles que des carcinomes. Médicaments pour le traitement des tumeurs contenant des quantités élevées de valépotriates. Ces médicaments, éventuellement associés aux traitements actuellement courants, conviennent aussi dans le cas des carcinomes susceptibles de former des métastases.
BE0/213197A 1983-06-22 1984-06-21 Nouvelles compositions pharmaceutiques antitumorales. BE899987A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3322337A DE3322337A1 (de) 1983-06-22 1983-06-22 Neue pharmazeutische zubereitungen mit antitumorwirkung

Publications (1)

Publication Number Publication Date
BE899987A true BE899987A (fr) 1984-10-15

Family

ID=6202002

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213197A BE899987A (fr) 1983-06-22 1984-06-21 Nouvelles compositions pharmaceutiques antitumorales.

Country Status (6)

Country Link
EP (1) EP0129822A3 (fr)
JP (1) JPS6013713A (fr)
BE (1) BE899987A (fr)
DE (1) DE3322337A1 (fr)
GB (1) GB2141930A (fr)
IT (1) IT1196147B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58188774U (ja) * 1982-06-10 1983-12-15 ジューキ株式会社 自動縫製装置の制御装置
JPH0194893A (ja) * 1987-09-24 1989-04-13 Frankl & Kirchner Gmbh & Co Kg Fab Elektromot 工業用ミシン
CN105541780B (zh) * 2016-03-02 2017-02-08 杭州市第一人民医院 一类缬草素衍生物、含其的药物组合物及其在抗肿瘤中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2011235A1 (en) * 1970-03-10 1971-10-14 Sons geb Heimbach, Ruth, 4050 Mönchengladbach, Heimbach, Irmgard, 4060 Viersen Anti-inflammatory compns with penetratingproperties
DE2849029A1 (de) * 1978-11-11 1980-05-22 Kali Chemie Pharma Gmbh Stabile valepotriat-zubereitungen und verfahren zu deren herstellung

Also Published As

Publication number Publication date
JPS6013713A (ja) 1985-01-24
GB2141930A (en) 1985-01-09
DE3322337A1 (de) 1986-05-15
EP0129822A3 (fr) 1985-09-11
IT1196147B (it) 1988-11-10
IT8421431A1 (it) 1985-12-15
GB8415453D0 (en) 1984-07-25
IT8421431A0 (it) 1984-06-15
EP0129822A2 (fr) 1985-01-02

Similar Documents

Publication Publication Date Title
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
SE9301951D0 (sv) Methods for administration of taxol
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
FI941771A (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
DE3687224D1 (de) Hemmung vom 5-lipoxygenase-weg.
FR2558373B1 (fr) Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
NZ308789A (en) Tetralin derivatives and medicaments
BG105302A (en) Means for improving cognition
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
CO4230093A1 (es) Derivados del indol y sus usos medicos
HUP9900978A2 (hu) Dioszgenint tartalmazó készítmény
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
BE899987A (fr) Nouvelles compositions pharmaceutiques antitumorales.
BE900959A (fr) Derives furyles de prostaglandines 16-substituees et procede pour leur fabrication.
ATE50143T1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
KR960700734A (ko) 사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers)
ATE44467T1 (de) Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
EP0093497A3 (fr) Traitement anthelminthique
DE3380165D1 (en) Analgesic combinations
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
KR900017599A (ko) 종양 치료용 약학 조성물
GB1327465A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
KR940011006A (ko) 황금추출물을 유효성분으로 하는 치주질환예방 및 치료제 조성물

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: KALI-CHEMIE PHARMA G.M.B.H.

Effective date: 19880630